A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim

A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim

Checkpoint inhibitors (CPIs) and pegfilgrastim, a long-acting growth factor agent, are vital components of current cancer treatments. Immune-related adverse events (irAEs) such as colitis and pneumonitis are well-established toxicities associated with CPI therapy. However, large-vessel vasculitis se...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Mort, Shipra Maheshwari, Nayanika Basu, Patrick Dillon, Kevin Brady, Harry Bear, Trish Millard
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2022/7295305
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items